BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30921645)

  • 1. A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection.
    Zhuang Q; Liu X; Sun Z; Wang H; Jiang J
    J Pharm Biomed Anal; 2019 Jun; 170():112-123. PubMed ID: 30921645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
    Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of free and total vincristine in human plasma after intravenous administration of vincristine sulfate liposome injection using ultra-high performance liquid chromatography tandem mass spectrometry.
    Yang F; Wang H; Liu M; Hu P; Jiang J
    J Chromatogr A; 2013 Feb; 1275():61-9. PubMed ID: 23294995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats.
    Basu S; Zeng M; Yin T; Gao S; Hu M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():34-41. PubMed ID: 26894853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of free and encapsulated cytarabine and daunorubicin in rat plasma after intravenous administration of liposomal formulation using ultra-high performance liquid chromatography tandem mass spectrometry.
    Li S; Zeng S; Wei BP; Wu Q; Liu C; Song PY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1200():123275. PubMed ID: 35551041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
    Marangon E; Posocco B; Mazzega E; Toffoli G
    PLoS One; 2015; 10(2):e0118194. PubMed ID: 25689738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid and sensitive UPLC-MS/MS method for determination of HZ08 in rat plasma and tissues: application to a pharmacokinetic study of liposome injections.
    Yan F; Sun M; Hang T; Sun J; Zhou X; Deng X; Ge L; Qian H; Ya D; Huang W
    J Pharm Biomed Anal; 2015 Jan; 102():246-52. PubMed ID: 25305722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An UPLC-MS/MS method to determine CT-707 and its two metabolites in plasma of ALK-positive advanced non-small cell lung cancer patients.
    Cui C; Hu P; Jiang J; Kong F; Luo H; Zhao Q
    J Pharm Biomed Anal; 2018 May; 153():1-8. PubMed ID: 29455091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
    Park DJ; Won JH; Cho AR; Yun HJ; Heo JH; Hwhang TH; Lee DH; Kim WM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():147-152. PubMed ID: 24927278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
    Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Puangpetch A; Prommas S; Sirilerttrakul S; Rerkarmnuaychoke B; Wongwaisayawan S; Sukasem C
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28393405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics.
    Goldwirt L; Lemaitre F; Zahr N; Farinotti R; Fernandez C
    J Pharm Biomed Anal; 2012 Jul; 66():325-33. PubMed ID: 22551773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of morphine-6-d-glucuronide, morphine-3-d-glucuronide and morphine in human plasma and urine by ultra-performance liquid chromatography-tandem mass spectrometry: Application to M6G injection pharmacokinetic study.
    Xu W; Zhuang Q; Chen X; Jiang J; Hu P; Wang H
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28833311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive UPLC-MS/MS method for simultaneous determination of eleven bioactive components of Tong-Xie-Yao-Fang decoction in rat biological matrices.
    Li TX; Hu L; Zhang MM; Sun J; Qiu Y; Rui JQ; Yang XH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():90-100. PubMed ID: 24295908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validated UPLC-MS/MS method for the quantitation of an unstable peptide, monocyte locomotion inhibitory factor (MLIF) in human plasma and its application to a pharmacokinetic study.
    Liu X; Hu P; Wang Y; Wang X; Huang J; Li J; Li C; Wang H; Jiang J
    J Pharm Biomed Anal; 2018 Aug; 157():75-83. PubMed ID: 29775810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of parecoxib sodium and its active metabolite valdecoxib in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study after intravenous and intramuscular administration.
    Liu M; Yu Q; Li P; Zhu M; Fang M; Sun B; Sun M; Sun Y; Zhang P; He Z; Sun J; Wang Y; Liu X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():220-229. PubMed ID: 27107851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation.
    Yang W; Yang Z; Liu J; Liu D; Wang Y
    Asian J Pharm Sci; 2019 Nov; 14(6):687-697. PubMed ID: 32104495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a UPLC-MS/MS method for quantitation of metronidazole and 2-hydroxy metronidazole in human plasma and its application to a pharmacokinetic study.
    Stancil SL; van Haandel L; Abdel-Rahman S; Pearce RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():272-278. PubMed ID: 29933220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of kurarinone in rat plasma by UPLC-MS/MS.
    Zhang WM; Li RF; Qiu JF; Zhang ZY; Wang HB; Bian L; Lei JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():31-4. PubMed ID: 25703950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated UPLC-MS/MS method coupled with protein precipitation and ion exchange solid phase extraction for the quantitation of porcine relaxin B29 in dog plasma and its application to a pharmacokinetic study.
    Su C; Sun H; Yang H; Yin L; Zhang J; Fawcett JP; Gu J
    Anal Bioanal Chem; 2017 Nov; 409(28):6559-6565. PubMed ID: 28889219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.